|
⚲
|
| Knopp Neurosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001347819 |
| Sale | 2009-09-21 ($12.5 M Offered, $8.5 M Sold) |
| Fund | |
| Phone | 4124881776 |
| Address | 2100 Wharton Street Pittsburgh, 15203 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Valentin Gribkoff | |
| Thomas Jr Petzinger | |
| Jeffrey McCormick | |
| Evan Ingersoll | |
| Gregory Hebrank | |
| Michael Bozik | |
| Ben Gomez |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
The New Normal Fund, LP - B1
✚
|
0.0 | |
|
Thorpe Allen R
✚
|
0.0 | |
|
Thoughtful Money LLC
✚
|
0.0 | |
|
Thrive 2022 SPV, a Series of SVG Thrive Accelerator Fund, LL
✚
|
0.0 | |
|
T H S Constructors, Inc.
✚
|
0.0 | |
|
Thyron Pharmaceuticals, Inc.
✚
|
0.0 | |
|
Tiny Rolling Fund, LP - A2
✚
|
0.0 | |
|
Tobin David Richard Jr
✚
|
0.0 | |
|
Tobin Edward
✚
|
0.0 | |
|
The New Normal Fund, LP - A4
✚
|
0.0 |